MassMutual Private Wealth & Trust’s PTC Therapeutics PTCT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.85K	Buy	35 +3	+9%	+$217	﹤0.01%	1887
2026 Q1	$2.18K	Buy	+32	New	+$2.27K	﹤0.01%	1957
2025 Q2	–	Sell	-106	Closed	-$5.4K	–	2470
2025 Q1	$5.4K	Buy	+106	New	+$5.29K	﹤0.01%	1570
2023 Q4	–	Sell	-61	Closed	-$1.37K	–	2062
2023 Q3	$1.37K	Buy	61 +30	+97%	+$1.12K	﹤0.01%	1605
2023 Q2	$1.26K	Hold	31	–	–	﹤0.01%	1600
2023 Q1	$1.5K	Hold	31	–	–	﹤0.01%	1494
2022 Q4	$1K	Hold	31	–	–	﹤0.01%	1521
2022 Q3	$2K	Hold	31	–	–	﹤0.01%	1273
2022 Q2	$1K	Buy	+31	New	+$1.09K	﹤0.01%	1384
2022 Q1	–	Sell	-17	Closed	-$1K	–	1610
2021 Q4	$1K	Buy	+17	New	+$651	﹤0.01%	1288

Other funds holding PTCT

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

MassMutual Private Wealth & Trust's PTCT Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its PTC Therapeutics (PTCT) stake by 9.4% in Q2 2026, buying an estimated $217 and bringing the position to 35 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1887.

MassMutual Private Wealth & Trust first reported a position in PTCT in Q4 2021 and has held it in 10 quarters since. The position peaked at $5.4K in Q1 2025. 103 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

MassMutual Private Wealth & Trust held 35 shares of PTC Therapeutics worth $2.85K as of Q2 2026.
MassMutual Private Wealth & Trust bought 3 PTC Therapeutics shares in Q2 2026, an estimated $217.
PTC Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1887 holding.
MassMutual Private Wealth & Trust first reported a position in PTC Therapeutics in Q4 2021 and has held it in 10 quarters since.
MassMutual Private Wealth & Trust's PTC Therapeutics position peaked at $5.4K in Q1 2025.
103 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.